Blumenthal M, ed. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Trans. S. Klein. Boston, MA: American Botanical Council, 1998.

Gruenwald J, Brendler T, Jaenicke C. PDR for Herbal Medicines. 1st ed. Montvale, NJ: Medical Economics Company, Inc., 1998.

Westendorf J, Pfau W, Schulte A. Carcinogenicity and DNA adduct formation observed in ACI rats after long-term treatment with madder root, Rubia tinctorum L. Carcinogenesis 1998;19:2163-8. View abstract.

Weiner MA, Weiner JA. Herbs that heal: prescription for herbal healing. Mill Valley, CA:Quantum Books, 1999.

Fetrow CW, Avila JR. Professional's Handbook of Complementary & Alternative Medicines. 1st ed. Springhouse, PA: Springhouse Corp., 1999.

Norton SA. Useful plants of dermatology. IV. Alizarin red and madder. J Am Acad Dermatol 1998;39(3):484-485. View abstract.

Castelain M, Ducombs G. Contact dermatitis from madder. Contact Dermatitis 1988;19(3):228-229. View abstract.

Blomeke B, Poginsky B, Schmutte C, Marquardt H, Westendorf J. Formation of genotoxic metabolites from anthraquinone glycosides, present in Rubia tinctorum L. Mutat Res 1992;265(2):263-272. View abstract.

Poginsky B, Westendorf J, Blomeke B, et al. Evaluation of DNA-binding activity of hydroxyanthraquinones occurring in Rubia tinctorum L. Carcinogenesis 1991;12(7):1265-1271. View abstract.

Ino N, Tanaka T, Okumura A, et al. Acute and subacute toxicity tests of madder root, natural colorant extracted from madder (Rubia tinctorum), in (C57BL/6 X C3H)F1 mice. Toxicol Ind Health 1995;11(4):449-458. View abstract.

Kawasaki Y, Goda Y, Yoshihira K. The mutagenic constituents of Rubia tinctorum. Chem Pharm Bull (Tokyo) 1992;40(6):1504-1509. View abstract.

Westendorf J, Poginsky B, Marquardt H, Groth G, Marquardt H. The genotoxicity of lucidin, a natural component of Rubia tinctorum L., and lucidinethylether, a component of ethanolic Rubia extracts. Cell Biol Toxicol 1988;4(2):225-239. View abstract.

Brinkworth RI, Fairlie DP. Hydroxyquinones are competitive non-peptide inhibitors of HIV-1 proteinase. Biochim Biophys Acta 1995;1253(1):5-8. View abstract.

Lorenz D, Lucker PW, Krumbiegel G, Mennicke WH, Wetzelsberger N. Pharmacokinetic studies of alizarin in man. Methods Find Exp Clin Pharmacol 1985;7(12):637-643. View abstract.

Boldizsár I, Szucs Z, Füzfai Z, Molnár-Perl I. Identification and quantification of the constituents of madder root by gas chromatography and high-performance liquid chromatography. J Chromatogr A 2006;1133(1-2):259-74. View abstract.

Kalyoncu F, Cetin B, Saglam H. Antimicrobial activity of common madder (Rubia tinctorum L.). Phytother Res. 2006 Jun;20(6):490-2. View abstract.

Karim A, Mekhfi H, Ziyyat A, et al. Anti-diarrhoeal activity of crude aqueous extract of Rubia tinctorum L. roots in rodents. J Smooth Muscle Res. 2010;46(2):119-23. View abstract.

Manojlovic NT, Solujic S, Sukdolak S, Milosev M. Antifungal activity of Rubia tinctorum, Rhamnus frangula and Caloplaca cerina. Fitoterapia. 2005;76(2):244-6. View abstract.

Marhoume FZ, Aboufatima R, Zaid Y, et al. Antioxidant and Polyphenol-Rich Ethanolic Extract of Rubia tinctorum L. Prevents Urolithiasis in an Ethylene Glycol Experimental Model in Rats. Molecules 2021;26(4):1005. View abstract.